Skip to search formSkip to main contentSkip to account menu

LY335979

Known as: LY 335979 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

zosuquidar trihydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Data demonstrating the challenges of determining the kinetic parameters of P-gp mediated transport of low-water soluble substrates
2016
2016
Metalloprobes: Fluorescence imaging of multidrug resistance (MDR1) P-Glycoprotein (Pgp)-mediated functional transport activity in cellulo.
2015
2015
P-Glycoprotein ( ABCB 1 ) Limits the Brain Distribution of YQA-14 , a Novel Dopamine D 3 Receptor Antagonist
Fei Liu,a,b,# Xiaoqing Wang,a,# Zheng Li,b Jin Li,b Xiaomei Zhuang,*,b and Zhenqing Zhang*,b a Department of Pharmacy, The First… 
2012
2012
Abstract 779: Prodrug-mediated reversal of multidrug resistance in breast cancer cells
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL The P-glycoprotein (P-gp) is a 170 kDa protein… 
2011
2011
Abstract 1703: Importance of pregnane X receptor (PXR) and P-glycoprotein (MDR1) to tamoxifen response and endoxifen disposition
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Tamoxifen, a widely prescribed anti-estrogen for… 
2009
2009
TAK-285, a Novel HER2/EGFR Inhibitor, Penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).
Background: Approximately one third of patients with HER2-overexpressing (HER2+) metastatic breast cancer develop brain… 
2008
2008
Role of xenobiotic efflux transporters in resistance to vincristine.
2003
2003
Bioanalysis of zosuquidar trihydrochloride (LY335979) in small volumes of human and murine plasma by ion-pairing reversed-phase high-performance liquid chromatography.
1998
1998
Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat…
Compound LY335979 is a P-glycoprotein inhibitor currently entering phase I clinical trials for potential reversal of multidrug… 
1998
1998
MASS SPECTROMETRY IDENTIFICATION OF NOVEL METABOLITES OF THE MULTIDRUG RESISTANCE MODULATOR LY 335979 IN RAT BILE AND HUMAN LIVER MICROSOMAL INCUBATIONS
Compound LY335979 is a P-glycoprotein inhibitor currently entering phase I clinical trials for potential reversal of multidrug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)